Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Cancer-associated cachexia is defined by loss of weight and muscle mass, and by the potential loss of adipose tissue accompanied by insulin resistance and increased resting energy expenditure. Cachexia is most prevalent in pancreatic cancer, the third leading cause of cancer-related deaths. While various factors interact to induce cachexia, the precise mechanisms underlying this clinical condition are not fully understood. Clinically relevant animal models of cachexia are needed given the lack of standard diagnostic methods or treatments for this condition. Described in this article are in vitro and in vivo models used to study the role of macrophages in the induction of cachexia in pancreatic cancer. Included are procedures for isolating and culturing bone marrow-derived macrophages, harvesting tumor- and macrophage-derived conditioned medium, and studying the effect of conditioned medium on C2C12 myotubes. Also described are procedures involving the use of an orthotopic model of pancreatic cancer, including a method for examining skeletal muscle atrophy in this model. © 2020 Wiley Periodicals LLC. Basic Protocol 1: In vitro model of pancreatic tumor-induced cachexia using C2C12 cell lines (myotube model) Support Protocol 1: Molecular evaluation of cachectic markers in C2C12 myotubes using real-time PCR and immunoblotting Basic Protocol 2: In vivo model to study cachectic phenotype in pancreatic tumor-bearing mice Support Protocol 2: Evaluation of cachectic markers in the skeletal muscle of tumor-bearing mice.
['Markov|Spas Dimitrov|SD|', 'Gonzalez|Daisy|D|', 'Mehla|Kamiya|K|']
D000818:Animals D002100:Cachexia D018929:Cell Culture Techniques D002460:Cell Line D017077:Culture Media, Conditioned D008264:Macrophages D051379:Mice D008810:Mice, Inbred C57BL D018485:Muscle Fibers, Skeletal D018482:Muscle, Skeletal D009133:Muscular Atrophy D010190:Pancreatic Neoplasms
cachexia pancreatic cancer skeletal muscle MyHC myotube atrophy